The Consortium

Located in Philadelphia, PA, The Consortium operates in PA's broader addiction-treatment market. The specific care levels offered by The Consortium should be confirmed directly with the admissions team. What this page tries to do is frame the specific questions worth asking, which are rarely the ones that get asked first.

Care levels at The Consortium

What The Consortium offers: Care-level specifics for The Consortium are not well-documented in the public SAMHSA record; a direct conversation with the admissions team is the reliable way to confirm what the facility actually provides. What matters is whether that matches the specific clinical picture, which only a proper assessment can tell. Most mismatches happen when the assessment is skipped or done inside the facility with a commercial interest in admission.

Insurance and payment

Payment and insurance specifics for The Consortium are not fully documented in the SAMHSA registry — a direct admissions conversation is the reliable way to confirm what forms of payment are accepted and at what network-contract level. The uncomfortable truth about insurance at most treatment centers is that admissions staff and the utilization-review team sometimes have different understandings of what was promised. Written VOB forces those understandings into alignment.

Before you call

Questions that matter before admitting to The Consortium: ASAM level of care (not the facility's category, the clinical level); written VOB; MAT policy. If the clinical situation involves opioid use disorder, confirm explicitly whether The Consortium offers medication-assisted treatment — buprenorphine, methadone, or naltrexone. Programs that do not are operating outside the current standard of care. The ones who answer those quickly are usually the ones worth considering. The ones who dodge are almost always worth skipping.